Keywords: LAIV; live attenuated influenza vaccine; NHS; National Health Service; PHE; Public Health England; Vaccine hesitancy; Influenza vaccine; Vaccination programme; England;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Influenza; Swine; Vaccine; LAIV; Antibodies;
Keywords: Influenza; Vaccination; Uptake; Child; Adult; BME; black or minority ethnic; PHE; Public Health England; LAIV; Attenuated Influenza Vaccine; LSOA; Lower Super Output Area; IMD; Index for Multiple Deprivation; ONS; Office for National Statistics;
Keywords: ACIP; Advisory Committee on Immunization Practices; CI; confidence interval; IIV; inactivated influenza vaccine; IIV3; trivalent IIV; IIV4; quadrivalent IIV; LAIV; live attenuated influenza vaccine; LAIV3; trivalent LAIV; LAIV4; quadrivalent LAIV; LINKS;
Keywords: Vaccines; Herd-effects; Generalized herd-effects; LAIV; Influenza; Pneumococcus; Coinfection;
Keywords: ACIP; Advisory Committee on Immunization Practices; CI; Confidence Interval; ED; Emergency Department; HEDIS; Health Plan Employer Data and Information Set; ICD9; International Classification of Disease, 9th Revision, Clinical Modification; IIV; inactivat
Keywords: LAIV; Quadrivalent live attenuated influenza vaccine; Pediatrics;
Keywords: SLIV; school-located influenza vaccination; VFC; Vaccines for Children; LAIV; Live Attenuated Influenza Vaccine; ACHD; Alachua County Health Department; Influenza vaccination; Immunization; Insurance; Cost; School health services; School-aged population;
Keywords: Egg allergy; live attenuated influenza vaccine; asthma; recurrent wheezing; safety; BTS; British Thoracic Society; IIV; Inactivated influenza vaccine; IQR; Interquartile range; LAIV; Live attenuated influenza vaccine; SIGN; Scottish Intercollegiate Guidel
Keywords: ACIP; Advisory Committee on Immunization Practices; ADEM; acute disseminated encephalomyelitis; AE; adverse events; AIDP; acute inflammatory demyelinating polyradiculoneuropathy; AMAN; acute motor axonal neuropathy; AMSAN; acute motor and sensory neuropat
Keywords: CMI; cellular mediated immunity; CoP; correlate of protection; ELISA; enzyme-linked immunosorbent assay; HA; haemagglutinin; HI; haemagglutination inhibition assay; HPAIV; highly pathogenic avian influenza viruses; HPLC; high-performance liquid chromatogr
Keywords: Food allergy; medication allergy; vaccine allergy; IIV; Inactivated influenza vaccine; ILE; Intravenous lipid emulsion; LAIV; Live attenuated influenza vaccine; TPN; Total parenteral nutrition;
Keywords: AGI; acute gastrointestinal tract; ART; acute respiratory tract; AW; asthma and wheezing; ED; emergency department; FU; follow-up; HR; hazard ratio; KP; Kaiser Permanente; LAIV; live attenuated influenza vaccine; MAE; medically attended event; PSDI; presp
Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016
Keywords: Influenza; Pandemic influenza vaccine; Seasonal influenza vaccine; Universal influenza vaccine; Vaccine development; Nextgeneration influenza vaccine; ADCC; Antibody-dependent cell-mediated cytotoxicity; AE; Adverse event; CMI; cell-mediated immunity; CON
H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets
Keywords: Avian influenza; Leningrad; Ann Arbor; LAIV; Pandemic;
Recent trends in ZikV research: A step away from cure
Keywords: ZikV; GBS; Microcephaly; DNA vaccination; FDA; MPA DNA; ZPIV; LAIV; AGS-v;
The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells
Keywords: Influenza; Respiratory epithelial cells; LAIV; Vaccines;
Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials
Keywords: Influenza B virus; Influenza vaccine; Vaccine effectiveness; Influenza B lineage mismatch; Pre-seasonal immunity; Meta-analysis; Meta-regression; Ab; antibody, or predicted from antibody; CI; confidence interval; Fab; antibody density function; FCP; clini
BezpieczeÅstwo szczepieÅ profilaktycznych u chorych na choroby alergiczne
Keywords: szczepienia profilaktyczne; alergia na biaÅko jaja kurzego; anafilaksja; Preventive vaccinations; Egg allergy; Anaphylaxis; AAAAI; American Academy of Allergy, Asthma and Immunology; ACAAI; American College of Allergy, Asthma and Immunology; ACIP; Adviso
Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States
Keywords: CDC; US Centers for Disease Control and Prevention; E47; glutamic residue at position 47; IIV; inactivated influenza vaccine; LAIV; live attenuated influenza vaccine; SPSN; Sentinel Provider Surveillance Network; TNCC; test-negative case control; US; Unit
M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice
Keywords: ADCC; antibody-dependent cellular cytotoxicity; Aichi; influenza A/Aichi/2/1968; APC; allophycocyanin; BAL; bronchoalveolar lavage; BSA; bovine serum albumin; CPE; cytopathic effect; FCS; fetal calf serum; FITC; fluorescein isothiocyanate; HAI; hemaggluti
Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; CMI; cell-mediated immunity; COBRA; computationally optimized broadly reactive antigen; CoP; immune correlate of protection; HA; influenza haemagglutinin protein; HI; haemagglutination inhibition; IFN;
Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011â12 through 2013â14 influenza seasons
Keywords: ACIP; Advisory Committee on Immunization Practices; IIV; Inactivated Influenza Vaccine; LAIV; Live Attenuated Influenza Vaccine; NIS-Flu; National Immunization Survey-Flu; NIS; National Immunization Survey; NIS-Teen; National Immunization Survey-Teen; CAS
Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates
Keywords: H2N2; Influenza; Vaccine; LAIV; Non-human primate; Monkey;
An integrated multi-study analysis of serum HAI antibody responses to Ann Arbor strain live attenuated influenza vaccine in children and adults
Keywords: GMFR, geometric mean fold rise; GMT, geometric mean titer; HAI, hemagglutination-inhibition; IIV, inactivated influenza vaccine; LAIV, live attenuated influenza vaccineLive attenuated influenza vaccine; LAIV; Serum HAI response
Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
Keywords: Influenza; Live attenuated influenza vaccine; LAIV; TLR-3; Adjuvant; Mucosal IgA;
Afriflu2-Second international workshop on influenza vaccination in the African continent-8 November 2012, Cape Town (South Africa)
Keywords: DCVMN; developing countries vaccine manufacturers network; ILI; influenza-like illness; LAIV; live-attenuated influenza vaccine; SAGE; strategic advisory group of experts on immunisation; SARI; severe acute respiratory illness; TIV; trivalent inactivated
Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)
Keywords: BMFG; Bill & Melinda Gates Foundation; GABRIEL; global approach to biological research on infectious epidemics in low-income countries network; Hib; Haemophilus influenzae type b; HIV; human immunodeficiency virus; LAIV; live attenuated influenza vaccine;
Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines
Keywords: TNF; tumor necrosis factor; IL; interleukin; TIV; trivalent inactivated influenza vaccine; LAIV; live attenuated influenza vaccine; Influenza; Vaccine; Cytokine;
Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine
Keywords: CDC; Centers for Disease Control and Prevention; CI; confidence interval; HETL; Health and Environmental Testing Laboratory; LAIV; live attenuated influenza vaccine; RT-PCR; reverse transcription polymerase chain reaction; Absenteeism; Influenza; Influenz
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age
Keywords: ED; emergency department; FU; follow-up; HR; hazard ratio; KP; Kaiser Permanente; LAIV; intranasal live attenuated influenza vaccine; MAE; medically attended event; NE; not estimated; PSDI; prespecified diagnoses of interest; RAD; reactive airway disease;
Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales
Keywords: Influenza; Dynamic transmission model; Childhood vaccination scenarios; LAIV; TIV; Indirect protection; Herd immunity;
Adverse reactions to vaccines practice parameter 2012 update
Keywords: Vaccine; immunization; adverse reaction; allergy; influenza vaccine; egg allergy; AAAAI; American Academy of Allergy, Asthma & Immunology; AAP; American Academy of Pediatrics; ACAAI; American College of Allergy, Asthma & Immunology; CDC; US Centers for Di
Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic
Keywords: LAIV; GPO Thailand; Pandemic preparedness; Influenza capacity building;
Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
Keywords: ACIP; Advisory Committee on Immunization Practices; AE; adverse event; LAIV; live attenuated influenza vaccine; RE; reactogenicity event; RT-PCR; reverse transcriptase polymerase chain reaction; SNMC; significant new medical conditions; TCID50; Median tis
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer
Keywords: Influenza; Vaccine; Pandemic; Manufacturing; Technology transfer; LAIV; Capacity-building; Developing countries;
A pandemic influenza vaccine in India: From strain to sale within 12 months
Keywords: LAIV; H1N1; Influenza vaccine; Pandemic; Production; Developing countries;
Plasmablast-derived polyclonal antibody response after influenza vaccination
Keywords: ASC; antibody secreting cells; HAI; hemagglutination inhibition; LAIV; live attenuated influenza vaccine; PPAb; plasmablast-derived polyclonal antibodies; TIV; trivalent inactivated influenza vaccine; Influenza virus; Vaccines; Antibodies; Plasmablasts;
Bioprocess optimization for cell culture based influenza vaccine production
Keywords: Influenza virus; Vaccine production; Multiplicity of infection; MDCK cells; LAIV; Process optimization;
Influenza vaccine for pregnant women in resource-constrained countries: A review of the evidence to inform policy decisions
Keywords: ACIP; US Advisory Committee on Immunization Practices; ALRI; acute lower respiratory infections; EMEA; European Medicines Agency; FDA; US Food and Drug Administration; GACVS; WHO Global Advisory Committee on Vaccine Safety; HAI; serum hemagglutination inh
Influenza Vaccines: From Surveillance Through Production to Protection
Keywords: ACIP; Advisory Committee on Immunization Practices; CDC; Centers for Disease Control and Prevention; CI; confidence interval; COPD; chronic obstructive pulmonary disease; FDA; Food and Drug Administration; GBS; Guillain-Barré Syndrome; GISN; Global Influ
Clinical pearls for preventing, diagnosing, and treating seasonal and 2009 H1N1 influenza infection in patients with asthma
Keywords: Asthma; human influenza; vaccination; antiviral agents; egg hypersensitivity; LAIV; Live attenuated influenza vaccine; TIV; Trivalent inactivated vaccine;
An Update on Childhood and Adolescent Vaccines
Keywords: ACIP; Advisory Committee on Immunization Practices; CDC; Centers for Disease Control and Prevention; FDA; Food and Drug Administration; HPV; human papillomavirus; LAIV; live attenuated influenza vaccine; MCV; meningococcal conjugate vaccine; MPSV; meningo
Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials
Keywords: AEFI; adverse events following immunisation; AlPO4; aluminium phosphate; Al(OH)3; aluminium hydroxide; CHMP; Committee for Human Medicinal Products; ECBS; Expert Committee on Biological Standardisation; HAI; haemagglutination-inhibition; LAIV; live-attenu
Flu Myths: Dispelling the Myths Associated With Live Attenuated Influenza Vaccine
Keywords: ACIP; Advisory Committee on Immunization Practices; HAI; hemagglutination inhibition assay; HIV; human immunodeficiency virus; LAIV; live attenuated influenza vaccine; TIV; trivalent inactivated influenza vaccine;
Diagnostic discrimination of live attenuated influenza vaccine strains and community-acquired pathogenic strains in clinical samples
Keywords: PCR; RT-PCR; LAIV; Vaccine shedding; FluMist
Impact of a Winter Respiratory Virus Season on Patients With COPD and Association With Influenza Vaccination
Keywords: COPD; health-related quality of life; influenza virus; pulmonary function; vaccine; CL; confidence limit; CLDSI; chronic lung disease severity index; LAIV; trivalent, live-attenuated, cold-adapted influenza virus vaccine; LDI; laboratory-documented influe
Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process
Keywords: Cold-adapted influenza virus vaccine; FluMist®; LAIV; CAIV-T; Genetic stability
Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting
Keywords: Influenza virus; Vaccine; Cold-adapted; Attenuated; FluMist; LAIV; Genetic stability